IBRITUMOMAB TIUXETAN

IBRITUMOMAB TIUXETAN was reported 1523 times

IBRITUMOMAB TIUXETAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTI-MOUSE ANTIBODY INCREASED 1 0.5000
1 NODAL MARGINAL ZONE B-CELL LYMPHOMA RECURRENT 1 0.3333
2 FOLLICLE CENTRE LYMPHOMA, FOLLICULAR GRADE I, II, III REFRACTORY 2 0.2500
3 MENINGITIS TUBERCULOUS 128 0.2290
4 COLITIS HERPES 2 0.2000
5 FOLLICLE CENTRE LYMPHOMA, FOLLICULAR GRADE I, II, III STAGE IV 2 0.1250
6 CAPNOCYTOPHAGIA INFECTION 1 0.1250
7 HEPATITIS B VIRUS TEST 1 0.1250
8 CSF GRANULOCYTE COUNT ABNORMAL 1 0.0909
9 EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) RECURRENT 1 0.0833
10 HEPATIC ANGIOSARCOMA 6 0.0822
11 ARTERIOVENOUS FISTULA, ACQUIRED 1 0.0667
12 NEOPLASM GROWTH ACCELERATED 1 0.0625
13 DIVERTICULUM DUODENAL 1 0.0526
14 FUNGUS STOOL IDENTIFIED 1 0.0500
15 FOLLICLE CENTRE LYMPHOMA, FOLLICULAR GRADE I, II, III RECURRENT 1 0.0476
16 LUNG INFILTRATION MALIGNANT 1 0.0435
17 MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS 5 0.0410
18 IODINE UPTAKE INCREASED 1 0.0400
19 ERYTHROLEUKAEMIA 3 0.0395
20 B-CELL LYMPHOMA STAGE I 1 0.0303
21 CSF RED BLOOD CELL COUNT POSITIVE 1 0.0286
22 BRONCHIAL ULCERATION 1 0.0250
23 5Q MINUS SYNDROME 4 0.0250
24 AUDITORY NERVE DISORDER 1 0.0227
25 REFRACTORY ANAEMIA WITH AN EXCESS OF BLASTS 7 0.0224
26 NON-HODGKIN'S LYMPHOMA RECURRENT 2 0.0217
27 REFRACTORY ANAEMIA 4 0.0217
28 HAEMORRHAGIC TUMOUR NECROSIS 1 0.0213
29 TUMOUR ULCERATION 5 0.0211
30 REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA 2 0.0196
31 THROMBOANGIITIS OBLITERANS 2 0.0192
32 BODY TEMPERATURE 5 0.0187
33 KARYOTYPE ANALYSIS ABNORMAL 2 0.0183
34 AUTOLOGOUS BONE MARROW TRANSPLANTATION THERAPY 1 0.0179
35 NON-HODGKIN'S LYMPHOMA 23 0.0176
36 CHOLANGIOLITIS 1 0.0169
37 LYMPHOMA TRANSFORMATION 6 0.0167
38 BACTEROIDES BACTERAEMIA 1 0.0167
39 PURPURA SENILE 2 0.0164
40 MESENTERIC ARTERY STENOSIS 2 0.0164
41 ACUTE MYELOMONOCYTIC LEUKAEMIA 4 0.0159
42 ACUTE ERYTHROID LEUKAEMIA 1 0.0159
43 REFRACTORY CYTOPENIA WITH UNILINEAGE DYSPLASIA 3 0.0152
44 FOLLICLE CENTRE LYMPHOMA, FOLLICULAR GRADE I, II, III 1 0.0149
45 CULTURE STOOL POSITIVE 4 0.0146
46 OSTEOMYELITIS BACTERIAL 4 0.0146
47 GALLBLADDER CANCER METASTATIC 1 0.0141
48 MYELOBLAST COUNT INCREASED 1 0.0130
49 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 18 0.0127
50 KLEBSIELLA TEST POSITIVE 8 0.0123
51 BONE MARROW LEUKAEMIC CELL INFILTRATION 1 0.0122
52 ANTI-ERYTHROCYTE ANTIBODY POSITIVE 1 0.0122
53 MYOPATHY STEROID 1 0.0118
54 ENCEPHALITIS CYTOMEGALOVIRUS 5 0.0114
55 TUBERCULOSIS OF CENTRAL NERVOUS SYSTEM 3 0.0111
56 B-CELL LYMPHOMA RECURRENT 6 0.0110
57 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 90 0.0109
58 INFUSION SITE ULCER 1 0.0109
59 STEM CELL TRANSPLANT 27 0.0108
60 CSF GLUCOSE INCREASED 1 0.0104
61 DIALYSIS HYPOTENSION 1 0.0101
62 HAEMODILUTION 1 0.0101
63 MENINGEAL DISORDER 4 0.0099
64 THROMBOPHLEBITIS SEPTIC 2 0.0098
65 BURKITT'S LYMPHOMA 1 0.0095
66 BACTERIAL TRANSLOCATION 3 0.0095
67 HERPES OESOPHAGITIS 2 0.0093
68 MANTLE CELL LYMPHOMA RECURRENT 4 0.0092
69 GAMMA-GLUTAMYLTRANSFERASE 1 0.0092
70 PARALYSIS FLACCID 2 0.0091
71 CATHETER THROMBOSIS 1 0.0089
72 PARANEOPLASTIC SYNDROME 6 0.0089
73 ANGIOSARCOMA 4 0.0087
74 DACRYOCANALICULITIS 1 0.0085
75 APLASIA 16 0.0082
76 CARCINOMA IN SITU OF SKIN 1 0.0080
77 ABDOMINAL WALL INFECTION 1 0.0075
78 HAEMOSIDEROSIS 2 0.0075
79 CHROMOSOME ABNORMALITY 1 0.0072
80 OCCUPATIONAL EXPOSURE TO TOXIC AGENT 2 0.0070
81 SUBCUTANEOUS NODULE 2 0.0069
82 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 19 0.0069
83 CLOSTRIDIUM DIFFICILE TOXIN TEST POSITIVE 1 0.0068
84 MYELODYSPLASTIC SYNDROME 98 0.0068
85 ENGRAFTMENT SYNDROME 4 0.0068
86 RADIATION INJURY 7 0.0066
87 CERVIX CARCINOMA STAGE I 1 0.0065
88 IMPLANT SITE WARMTH 1 0.0065
89 NEOPLASM PROSTATE 2 0.0064
90 MUCOSAL NECROSIS 1 0.0064
91 CHROMOSOMAL DELETION 1 0.0063
92 CYTOGENETIC ABNORMALITY 7 0.0062
93 PARAKERATOSIS 2 0.0062
94 ACUTE HEPATITIS B 2 0.0060
95 CATHETER RELATED INFECTION 6 0.0059
96 MANTLE CELL LYMPHOMA 9 0.0059
97 PNEUMONIA INFLUENZAL 7 0.0059
98 UPPER RESPIRATORY TRACT INFLAMMATION 7 0.0058
99 ATHETOSIS 1 0.0057
100 ENCEPHALITIS VIRAL 7 0.0057
101 JC VIRUS INFECTION 9 0.0056
102 CORONARY ARTERY INSUFFICIENCY 2 0.0056
103 GASTROENTERITIS ESCHERICHIA COLI 3 0.0055
104 PERIRECTAL ABSCESS 6 0.0054
105 SPLENIC LESION 2 0.0054
106 BLOOD ALKALINE PHOSPHATASE 1 0.0054
107 CENTRAL LINE INFECTION 2 0.0054
108 LUNG INFECTION PSEUDOMONAL 3 0.0054
109 ASPERGILLOSIS 7 0.0054
110 INTESTINAL ADENOCARCINOMA 1 0.0053
111 ACINETOBACTER BACTERAEMIA 1 0.0053
112 METASTATIC BRONCHIAL CARCINOMA 1 0.0052
113 SKIN TURGOR DECREASED 2 0.0052
114 GRANULOCYTES ABNORMAL 1 0.0050
115 GASTROENTERITIS CRYPTOSPORIDIAL 1 0.0049
116 BRONCHOALVEOLAR LAVAGE ABNORMAL 1 0.0048
117 POLYSEROSITIS 2 0.0047
118 CYTOMEGALOVIRUS GASTROENTERITIS 1 0.0046
119 DIABETIC HYPEROSMOLAR COMA 2 0.0046
120 FOLLICULAR LYMPHOMA 4 0.0045
121 CHRONIC MYELOMONOCYTIC LEUKAEMIA 3 0.0045
122 HUMAN HERPES VIRUS 6 SEROLOGY POSITIVE 1 0.0045
123 HERPES SIMPLEX 29 0.0045
124 NO ADVERSE DRUG EFFECT 3 0.0044
125 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 1 0.0043
126 GRAFT VERSUS HOST DISEASE IN EYE 1 0.0043
127 RADIATION SKIN INJURY 5 0.0043
128 MUCOSAL INFECTION 1 0.0043
129 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 3 0.0042
130 BIOPSY SKIN ABNORMAL 1 0.0042
131 VENOOCCLUSIVE LIVER DISEASE 20 0.0040
132 MONONUCLEOSIS SYNDROME 1 0.0039
133 LEUKAEMOID REACTION 1 0.0038
134 ESCHERICHIA BACTERAEMIA 9 0.0038
135 CRYPTOSPORIDIOSIS INFECTION 2 0.0038
136 RETROPERITONEAL LYMPHADENOPATHY 2 0.0038
137 HUMAN POLYOMAVIRUS INFECTION 2 0.0038
138 ACUTE MYELOID LEUKAEMIA 58 0.0037
139 HUMAN HERPESVIRUS 6 INFECTION 7 0.0037
140 VENOOCCLUSIVE DISEASE 9 0.0036
141 HEPATITIS C VIRUS 2 0.0036
142 PNEUMONIA PRIMARY ATYPICAL 2 0.0036
143 METASTASES TO BLADDER 1 0.0035
144 ENGRAFT FAILURE 1 0.0035
145 HAEMATOMA INFECTION 2 0.0035
146 CREUTZFELDT-JAKOB DISEASE 1 0.0035
147 ACUTE PRERENAL FAILURE 4 0.0035
148 MORGANELLA INFECTION 1 0.0034
149 GRAFT COMPLICATION 2 0.0034
150 AURICULAR SWELLING 2 0.0033
151 ENTEROCOCCAL INFECTION 16 0.0033
152 RECTAL ADENOCARCINOMA 2 0.0033
153 ASPERGILLUS TEST POSITIVE 1 0.0032
154 ARTHRITIS REACTIVE 2 0.0032
155 CAUSTIC INJURY 1 0.0032
156 BONE MARROW FAILURE 65 0.0032
157 NEUTROPHIL PERCENTAGE INCREASED 4 0.0032
158 BONE MARROW DEPRESSION 3 0.0031
159 INJECTION SITE THROMBOSIS 1 0.0030
160 PNEUMOCOCCAL SEPSIS 2 0.0030
161 EXTRADURAL HAEMATOMA 4 0.0030
162 BLOOD CULTURE POSITIVE 9 0.0030
163 LUNG ADENOCARCINOMA 9 0.0030
164 DECREASED VIBRATORY SENSE 1 0.0029
165 GIARDIASIS 1 0.0029
166 METASTATIC GASTRIC CANCER 1 0.0029
167 ATHEROSCLEROSIS 1 0.0029
168 ARACHNOIDITIS 2 0.0029
169 SECOND PRIMARY MALIGNANCY 24 0.0029
170 CHRONIC OBSTRUCTIVE AIRWAYS DISEASE EXACERBATED 1 0.0029
171 FUNGAL TEST POSITIVE 1 0.0028
172 PULMONARY SEPSIS 4 0.0027
173 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0027
174 MUCOSAL INFLAMMATION 72 0.0027
175 DYSPNOEA PAROXYSMAL NOCTURNAL 2 0.0027
176 ESSENTIAL THROMBOCYTHAEMIA 1 0.0027
177 HUMAN RHINOVIRUS TEST POSITIVE 1 0.0027
178 MEDIASTINAL DISORDER 1 0.0027
179 AMYOTROPHY 1 0.0026
180 PAROTITIS 3 0.0026
181 BONE MARROW INFILTRATION 1 0.0026
182 OBSTRUCTIVE UROPATHY 1 0.0025
183 LARYNGEAL PAIN 1 0.0025
184 LYMPHOCYTIC LEUKAEMIA 1 0.0025
185 EXTRAVASATION 10 0.0024
186 SEPTIC EMBOLUS 2 0.0024
187 CORONARY ARTERY ATHEROSCLEROSIS 1 0.0024
188 FEBRILE BONE MARROW APLASIA 10 0.0024
189 ANAL SPHINCTER ATONY 1 0.0023
190 OESOPHAGEAL CANDIDIASIS 9 0.0023
191 NEUROSIS 1 0.0022
192 HEAD TITUBATION 3 0.0022
193 OPPORTUNISTIC INFECTION 4 0.0022
194 URINARY TRACT INFECTION ENTEROCOCCAL 2 0.0021
195 INJECTION SITE ULCER 2 0.0021
196 HYPOPROTEINAEMIA 4 0.0021
197 CYTOMEGALOVIRUS INFECTION 35 0.0021
198 GRAFT VERSUS HOST DISEASE 15 0.0021
199 BLAST CELLS PRESENT 1 0.0021
200 EXERCISE LACK OF 1 0.0021
201 B-CELL LYMPHOMA 7 0.0021
202 CYTOMEGALOVIRUS CHORIORETINITIS 4 0.0020
203 MULTI-ORGAN FAILURE 35 0.0020
204 METASTASES TO BONE MARROW 1 0.0020
205 EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) 1 0.0020
206 COMPLICATIONS OF TRANSPLANT SURGERY 1 0.0020
207 THROMBOPHLEBITIS SUPERFICIAL 6 0.0020
208 CAROTID ARTERIOSCLEROSIS 2 0.0019
209 MYELODYSPLASTIC SYNDROME TRANSFORMATION 1 0.0019
210 ACUTE INTERSTITIAL PNEUMONITIS 1 0.0019
211 NO REACTION ON PREVIOUS EXPOSURE TO DRUG 1 0.0019
212 NEUTROPHIL PERCENTAGE DECREASED 1 0.0019
213 CORYNEBACTERIUM INFECTION 1 0.0019
214 LYMPHOCYTOSIS 4 0.0019
215 STAPHYLOCOCCAL BACTERAEMIA 8 0.0018
216 ARRHYTHMIA SUPRAVENTRICULAR 2 0.0018
217 GENITAL DISCOMFORT 1 0.0018
218 BLOOD PH INCREASED 1 0.0018
219 LARYNGEAL CANCER 2 0.0018
220 BRAIN SCAN ABNORMAL 1 0.0018
221 INTRAVASCULAR HAEMOLYSIS 1 0.0018
222 KLEBSIELLA SEPSIS 2 0.0018
223 LEGIONELLA INFECTION 1 0.0017
224 ACUTE GRAFT VERSUS HOST DISEASE 8 0.0017
225 CANDIDIASIS 7 0.0017
226 SKIN NECROSIS 9 0.0017
227 MUCOSAL HAEMORRHAGE 2 0.0017
228 AORTIC STENOSIS 6 0.0017
229 PSEUDOMONAL SEPSIS 3 0.0017
230 VERTIGO POSITIONAL 3 0.0017
231 LACUNAR INFARCTION 4 0.0017
232 ESCHERICHIA TEST POSITIVE 2 0.0017
233 CHRONIC GRAFT VERSUS HOST DISEASE 6 0.0017
234 DYSMETRIA 1 0.0017
235 LUNG NEOPLASM 7 0.0016
236 HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL 1 0.0016
237 STAPHYLOCOCCAL SKIN INFECTION 2 0.0016
238 PROTEIN TOTAL DECREASED 6 0.0016
239 PERIPHERAL SENSORIMOTOR NEUROPATHY 2 0.0016
240 BACILLUS INFECTION 1 0.0016
241 HYPOREFLEXIA 3 0.0016
242 THROMBOCYTOPENIA 174 0.0016
243 INTESTINAL ANASTOMOSIS 1 0.0016
244 SEPSIS 172 0.0015
245 BLOOD IMMUNOGLOBULIN A DECREASED 1 0.0015
246 EMBOLIC CEREBRAL INFARCTION 1 0.0015
247 LYMPHOCYTE PERCENTAGE DECREASED 2 0.0015
248 BLOOD LACTATE DEHYDROGENASE ABNORMAL 1 0.0015
249 NEOPLASM RECURRENCE 5 0.0015
250 IMMUNOGLOBULINS DECREASED 2 0.0015
251 CENTRAL NERVOUS SYSTEM LYMPHOMA 2 0.0015
252 RHONCHI 2 0.0014
253 SUBILEUS 3 0.0014
254 BRONCHOPULMONARY ASPERGILLOSIS 11 0.0014
255 FEBRILE NEUTROPENIA 94 0.0014
256 PANCYTOPENIA 78 0.0014
257 HODGKIN'S DISEASE 1 0.0014
258 ESCHAR 1 0.0014
259 HAEMATOTOXICITY 13 0.0014
260 PNEUMOCYSTIS JIROVECI PNEUMONIA 3 0.0013
261 APLASTIC ANAEMIA 7 0.0013
262 CATHETER SITE RELATED REACTION 1 0.0013
263 HYPERCAPNIA 4 0.0013
264 BONE MARROW DISORDER 4 0.0013
265 CLOSTRIDIUM DIFFICILE COLITIS 14 0.0013
266 METASTASES TO MENINGES 3 0.0013
267 GINGIVAL HYPERTROPHY 2 0.0013
268 CYTOMEGALOVIRUS COLITIS 3 0.0013
269 PNEUMONIA PSEUDOMONAL 2 0.0013
270 GENITAL ULCERATION 1 0.0013
271 MYOPERICARDITIS 1 0.0013
272 PSEUDOMONAS INFECTION 11 0.0013
273 GALLBLADDER POLYP 1 0.0013
274 ENDOCARDITIS BACTERIAL 1 0.0013
275 DIARRHOEA INFECTIOUS 1 0.0013
276 NEUTROPENIC SEPSIS 9 0.0013
277 DRUG TOXICITY 17 0.0012
278 BACTERIAL SEPSIS 4 0.0012
279 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 1 0.0012
280 ARTHRITIS BACTERIAL 5 0.0012
281 CSF PROTEIN INCREASED 1 0.0012
282 QUADRIPARESIS 2 0.0012
283 FUNGAL SEPSIS 1 0.0012
284 INCISION SITE COMPLICATION 1 0.0012
285 ENTEROBACTER INFECTION 2 0.0012
286 TONSILLAR HYPERTROPHY 2 0.0012
287 CLOSTRIDIAL INFECTION 4 0.0012
288 CANCER PAIN 3 0.0012
289 BRONCHOPNEUMONIA 4 0.0012
290 SQUAMOUS CELL CARCINOMA OF SKIN 7 0.0012
291 HYPOALBUMINAEMIA 9 0.0012
292 HILAR LYMPHADENOPATHY 1 0.0011
293 CEREBELLAR ATROPHY 1 0.0011
294 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
295 NUCHAL RIGIDITY 1 0.0011
296 MUSCLE NECROSIS 1 0.0011
297 INTESTINAL INFARCTION 1 0.0011
298 LYMPHOMA 17 0.0011
299 ENTEROCOLITIS INFECTIOUS 1 0.0011
300 METASTASES TO ADRENALS 1 0.0011
301 CHRONIC MYELOID LEUKAEMIA 5 0.0011
302 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0011
303 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0011
304 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 1 0.0011
305 ASPERGILLUS INFECTION 7 0.0011
306 MICROANGIOPATHY 1 0.0011
307 NEUTROPHIL COUNT ABNORMAL 3 0.0011
308 HEPATIC CONGESTION 1 0.0011
309 GRANULOCYTOPENIA 6 0.0011
310 NEUTROPENIC INFECTION 1 0.0010
311 LYMPHADENOPATHY MEDIASTINAL 2 0.0010
312 ENTEROCOLITIS 6 0.0010
313 COLON NEOPLASM 1 0.0010
314 NEUTROPENIA 141 0.0010
315 ESCHERICHIA SEPSIS 3 0.0010
316 HAEMOPHILUS INFECTION 1 0.0010
317 PYELONEPHRITIS ACUTE 2 0.0010
318 TRICUSPID VALVE INCOMPETENCE 8 0.0010
319 RESPIRATORY DISORDER 30 0.0010
320 MUCOSAL DRYNESS 2 0.0010
321 LYMPHOCYTIC INFILTRATION 1 0.0010
322 CYSTITIS HAEMORRHAGIC 4 0.0010
323 NEUTROPHIL COUNT DECREASED 40 0.0010
324 AXILLARY MASS 1 0.0010
325 BLOOD BLISTER 3 0.0010
326 PNEUMONIA VIRAL 3 0.0009
327 NEUROMYOPATHY 1 0.0009
328 ANAEMIA MACROCYTIC 2 0.0009
329 GALLBLADDER ENLARGEMENT 1 0.0009
330 HAEMORRHAGIC DISORDER 1 0.0009
331 CEREBELLAR SYNDROME 2 0.0009
332 DIFFUSE LARGE B-CELL LYMPHOMA 7 0.0009
333 LUNG INFILTRATION 8 0.0009
334 CYTOMEGALOVIRUS VIRAEMIA 4 0.0009
335 CARDIAC HYPERTROPHY 1 0.0009
336 CATHETER RELATED COMPLICATION 1 0.0009
337 BLOOD LACTATE DEHYDROGENASE INCREASED 14 0.0009
338 MITRAL VALVE INCOMPETENCE 10 0.0009
339 COMPUTERISED TOMOGRAM ABNORMAL 2 0.0009
340 LEUKOPENIA 44 0.0009
341 AUTOIMMUNE HAEMOLYTIC ANAEMIA 3 0.0009
342 INFECTION REACTIVATION 1 0.0009
343 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
344 DIFFUSE ALVEOLAR DAMAGE 1 0.0009
345 MACROCYTOSIS 1 0.0009
346 LICHEN PLANUS 2 0.0009
347 DILATATION ATRIAL 1 0.0009
348 RESPIRATORY FAILURE 62 0.0008
349 ACUTE LUNG INJURY 1 0.0008
350 DIABETES INSIPIDUS 2 0.0008
351 CEREBRAL ARTERY EMBOLISM 1 0.0008
352 RETROPERITONEAL HAEMORRHAGE 2 0.0008
353 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 2 0.0008
354 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
355 MALIGNANT MELANOMA IN SITU 1 0.0008
356 SKIN SWELLING 7 0.0008
357 SEPTIC SHOCK 35 0.0008
358 INTRADUCTAL PROLIFERATIVE BREAST LESION 1 0.0008
359 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
360 METASTASES TO PERITONEUM 2 0.0008
361 KLEBSIELLA INFECTION 4 0.0008
362 PLATELET COUNT DECREASED 84 0.0008
363 HYPERTHERMIA 6 0.0008
364 BRONCHIAL SECRETION RETENTION 1 0.0008
365 LIP HAEMORRHAGE 1 0.0008
366 HEPATOSPLENOMEGALY 2 0.0008
367 IATROGENIC INJURY 1 0.0008
368 BLOOD CHLORIDE DECREASED 2 0.0008
369 IMMUNE RECONSTITUTION SYNDROME 1 0.0008
370 VENTRICULAR DYSFUNCTION 2 0.0008
371 MUCORMYCOSIS 2 0.0008
372 WHITE BLOOD CELL COUNT DECREASED 83 0.0008
373 PNEUMONIA BACTERIAL 7 0.0008
374 STAPHYLOCOCCAL INFECTION 25 0.0008
375 NYSTAGMUS 4 0.0008
376 GASTROENTERITIS NOROVIRUS 1 0.0008
377 CYSTITIS NONINFECTIVE 1 0.0007
378 ORAL FUNGAL INFECTION 2 0.0007
379 ABSCESS ORAL 1 0.0007
380 ECCHYMOSIS 5 0.0007
381 GENERALISED OEDEMA 9 0.0007
382 DISEASE PROGRESSION 85 0.0007
383 ECHOCARDIOGRAM ABNORMAL 1 0.0007
384 LUNG CONSOLIDATION 2 0.0007
385 H1N1 INFLUENZA 1 0.0007
386 CULTURE URINE POSITIVE 1 0.0007
387 INTESTINAL FISTULA 1 0.0007
388 NEUROENDOCRINE TUMOUR 1 0.0007
389 HAEMATOCRIT DECREASED 14 0.0007
390 BLADDER TRANSITIONAL CELL CARCINOMA 1 0.0007
391 ADENOVIRUS INFECTION 2 0.0007
392 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 1 0.0007
393 BILIARY DILATATION 1 0.0007
394 ACUTE RESPIRATORY DISTRESS SYNDROME 12 0.0007
395 BLOOD PRESSURE DIASTOLIC DECREASED 5 0.0007
396 ATAXIA 8 0.0007
397 ADHESION 1 0.0007
398 TOXIC EPIDERMAL NECROLYSIS 10 0.0007
399 INFECTIOUS PLEURAL EFFUSION 1 0.0007
400 RECTAL CANCER 2 0.0007
401 PERFORMANCE STATUS DECREASED 3 0.0006
402 SQUAMOUS CELL CARCINOMA 6 0.0006
403 HEPATIC FAILURE 19 0.0006
404 HEPATITIS B REACTIVATION 2 0.0006
405 MALNUTRITION 7 0.0006
406 ENTERITIS 4 0.0006
407 GASTROINTESTINAL TOXICITY 3 0.0006
408 LIVER ABSCESS 2 0.0006
409 THROMBOTIC MICROANGIOPATHY 6 0.0006
410 HYPOVENTILATION 2 0.0006
411 CARDIOMYOPATHY 9 0.0006
412 HYPOGAMMAGLOBULINAEMIA 4 0.0006
413 STAPHYLOCOCCAL SEPSIS 3 0.0006
414 ANTIBODY TEST POSITIVE 1 0.0006
415 CYTOLYTIC HEPATITIS 2 0.0006
416 LINEAR IGA DISEASE 1 0.0006
417 DERMATITIS EXFOLIATIVE 3 0.0006
418 BK VIRUS INFECTION 2 0.0006
419 HEPATORENAL SYNDROME 1 0.0006
420 LEUKAEMIA RECURRENT 1 0.0006
421 CEREBELLAR INFARCTION 1 0.0006
422 CEREBRAL ISCHAEMIA 3 0.0006
423 CHOREA 1 0.0006
424 CERVICAL SPINAL STENOSIS 1 0.0006
425 LUNG INFECTION 9 0.0006
426 PERIORBITAL OEDEMA 3 0.0006
427 FAILURE TO THRIVE 3 0.0006
428 CHOLESTASIS 11 0.0006
429 THROMBOPHLEBITIS 2 0.0006
430 SPINAL OSTEOARTHRITIS 5 0.0006
431 EMBOLIC STROKE 2 0.0006
432 THROMBOTIC THROMBOCYTOPENIC PURPURA 2 0.0006
433 LYMPHOCYTE COUNT DECREASED 10 0.0006
434 LYMPHOPENIA 8 0.0006
435 BODY TEMPERATURE ABNORMAL 1 0.0005
436 HYPOPHOSPHATAEMIA 4 0.0005
437 STREPTOCOCCAL INFECTION 3 0.0005
438 ACCIDENTAL DEATH 1 0.0005
439 SKIN TOXICITY 3 0.0005
440 LIP DISORDER 1 0.0005
441 BONE MARROW TRANSPLANT 1 0.0005
442 NEUROLOGICAL SYMPTOM 3 0.0005
443 OESOPHAGEAL DISORDER 2 0.0005
444 PERIPHERAL SENSORY NEUROPATHY 3 0.0005
445 HYPOVOLAEMIA 3 0.0005
446 CERVIX CARCINOMA 2 0.0005
447 ASCITES 15 0.0005
448 OCCULT BLOOD POSITIVE 1 0.0005
449 EMPYEMA 1 0.0005
450 HYPOTONIA 5 0.0005
451 PNEUMOCYSTIS JIROVECII PNEUMONIA 5 0.0005
452 INJECTION SITE NECROSIS 1 0.0005
453 DEMYELINATION 2 0.0005
454 HYPERURICAEMIA 2 0.0005
455 NEUTROPENIC COLITIS 1 0.0005
456 ILEUS 6 0.0005
457 PLEURAL EFFUSION 29 0.0005
458 HAEMODIALYSIS 4 0.0005
459 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
460 AORTIC VALVE INCOMPETENCE 2 0.0005
461 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 1 0.0005
462 INTERVERTEBRAL DISC DISORDER 2 0.0005
463 CATHETER SITE ERYTHEMA 1 0.0005
464 CD4 LYMPHOCYTES DECREASED 1 0.0005
465 ACUTE MYELOID LEUKAEMIA RECURRENT 1 0.0005
466 EXOPHTHALMOS 1 0.0005
467 METASTATIC NEOPLASM 2 0.0005
468 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
469 ENDOMETRIAL CANCER 1 0.0005
470 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 1 0.0005
471 CYTOMEGALOVIRUS INFECTION REACTIVATION 2 0.0005
472 LYMPHADENOPATHY 16 0.0005
473 STEVENS-JOHNSON SYNDROME 10 0.0004
474 RENAL FAILURE ACUTE 19 0.0004
475 CALCINOSIS 1 0.0004
476 JOINT RANGE OF MOTION DECREASED 6 0.0004
477 ANAEMIA 84 0.0004
478 HAEMOGLOBIN DECREASED 45 0.0004
479 LARGE INTESTINE POLYP 3 0.0004
480 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1 0.0004
481 BILIRUBIN CONJUGATED INCREASED 1 0.0004
482 SPLENOMEGALY 5 0.0004
483 ARTERIOSCLEROSIS 4 0.0004
484 LEUKAEMIA 4 0.0004
485 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
486 CHRONIC LYMPHOCYTIC LEUKAEMIA 2 0.0004
487 SUBDURAL HAEMATOMA 6 0.0004
488 NO THERAPEUTIC RESPONSE 5 0.0004
489 HAEMATOLOGICAL INFECTION 1 0.0004
490 HYPERCALCAEMIA 5 0.0004
491 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
492 GASTROINTESTINAL TUBE INSERTION 1 0.0004
493 ERYSIPELAS 2 0.0004
494 EXCORIATION 1 0.0004
495 DEVICE RELATED INFECTION 6 0.0004
496 MEAN CELL VOLUME INCREASED 1 0.0004
497 RED BLOOD CELL COUNT DECREASED 11 0.0004
498 BASAL CELL CARCINOMA 6 0.0004
499 PULMONARY HAEMORRHAGE 3 0.0004
500 PETECHIAE 4 0.0004
501 ORAL CANDIDIASIS 5 0.0004
502 DISEASE RECURRENCE 18 0.0004
503 BLOOD ALBUMIN DECREASED 3 0.0004
504 ABDOMINAL MASS 1 0.0004
505 BLOOD BILIRUBIN INCREASED 10 0.0004
506 ESCHERICHIA INFECTION 3 0.0004
507 INTESTINAL ISCHAEMIA 2 0.0004
508 HYPERKERATOSIS 2 0.0004
509 HEPATOTOXICITY 8 0.0004
510 PULMONARY ALVEOLAR HAEMORRHAGE 2 0.0004
511 INTESTINAL PERFORATION 4 0.0004
512 MALIGNANT NEOPLASM PROGRESSION 36 0.0004
513 ANURIA 3 0.0003
514 MYOPATHY 3 0.0003
515 HERPES VIRUS INFECTION 2 0.0003
516 HYPOGLYCAEMIC COMA 1 0.0003
517 DYSPNOEA AT REST 1 0.0003
518 HAEMOTHORAX 1 0.0003
519 METABOLIC DISORDER 2 0.0003
520 GASTROINTESTINAL NECROSIS 1 0.0003
521 GASTRITIS 9 0.0003
522 METASTASES TO LIVER 6 0.0003
523 TUMOUR LYSIS SYNDROME 3 0.0003
524 CARDIOTOXICITY 3 0.0003
525 CREPITATIONS 1 0.0003
526 INFUSION SITE REACTION 1 0.0003
527 PROTHROMBIN TIME PROLONGED 2 0.0003
528 POLYNEUROPATHY 4 0.0003
529 METABOLIC ENCEPHALOPATHY 1 0.0003
530 HEPATITIS B 2 0.0003
531 CEREBROVASCULAR DISORDER 1 0.0003
532 HERPES ZOSTER 19 0.0003
533 LUNG DISORDER 16 0.0003
534 DYSAESTHESIA 1 0.0003
535 RESPIRATORY DISTRESS 9 0.0003
536 DUODENITIS 1 0.0003
537 INTRACARDIAC THROMBUS 1 0.0003
538 UROSEPSIS 3 0.0003
539 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
540 DIASTOLIC DYSFUNCTION 1 0.0003
541 MULTIPLE-DRUG RESISTANCE 1 0.0003
542 BACTERIAL INFECTION 6 0.0003
543 HEPATIC ENCEPHALOPATHY 3 0.0003
544 INFUSION SITE EXTRAVASATION 2 0.0003
545 HAEMOGLOBIN ABNORMAL 2 0.0003
546 ANOREXIA 4 0.0003
547 MYELOSUPPRESSION 11 0.0003
548 BREAST ENLARGEMENT 1 0.0003
549 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0003
550 METASTASES TO LYMPH NODES 2 0.0003
551 CANDIDA INFECTION 5 0.0003
552 DRY THROAT 3 0.0003
553 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
554 SUBARACHNOID HAEMORRHAGE 3 0.0003
555 APLASIA PURE RED CELL 1 0.0003
556 GRANULOMA 1 0.0003
557 MENTAL STATUS CHANGES 8 0.0003
558 BRONCHIOLITIS 1 0.0003
559 HYPOXIA 10 0.0003
560 HAEMORRHAGE SUBCUTANEOUS 1 0.0003
561 GLOSSITIS 1 0.0003
562 HYPOKALAEMIA 13 0.0003
563 HAEMORRHAGIC DIATHESIS 1 0.0003
564 STOMATITIS 17 0.0003
565 FACIAL BONES FRACTURE 1 0.0003
566 CAROTID ARTERY OCCLUSION 1 0.0003
567 MEDICAL DEVICE COMPLICATION 2 0.0003
568 FUNGAL INFECTION 9 0.0003
569 AGRANULOCYTOSIS 5 0.0003
570 COLON CANCER 4 0.0003
571 LUNG NEOPLASM MALIGNANT 11 0.0003
572 HEPATIC NECROSIS 1 0.0003
573 TROPONIN INCREASED 2 0.0003
574 HAEMODYNAMIC INSTABILITY 2 0.0003
575 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
576 NEOPLASM 3 0.0003
577 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
578 AZOTAEMIA 1 0.0003
579 BLOOD DISORDER 2 0.0002
580 ARTERIOSPASM CORONARY 1 0.0002
581 UTERINE CANCER 2 0.0002
582 INTERSTITIAL LUNG DISEASE 12 0.0002
583 CEREBRAL INFARCTION 6 0.0002
584 CARDIOMEGALY 3 0.0002
585 ACUTE CORONARY SYNDROME 2 0.0002
586 HEPATIC FUNCTION ABNORMAL 9 0.0002
587 EMBOLISM 2 0.0002
588 CONGESTIVE CARDIOMYOPATHY 1 0.0002
589 BLOOD UREA INCREASED 4 0.0002
590 ACUTE MYOCARDIAL INFARCTION 7 0.0002
591 GASTRIC CANCER 6 0.0002
592 CARDIAC FAILURE CHRONIC 1 0.0002
593 ALCOHOLISM 1 0.0002
594 RENAL FAILURE 31 0.0002
595 SKIN ULCER 6 0.0002
596 HEPATIC LESION 1 0.0002
597 IMMOBILE 1 0.0002
598 DIVERTICULUM INTESTINAL 1 0.0002
599 NAIL DISORDER 2 0.0002
600 TOOTH INFECTION 3 0.0002
601 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
602 PNEUMONIA 73 0.0002
603 RESPIRATORY RATE INCREASED 2 0.0002
604 TRANSAMINASES INCREASED 5 0.0002
605 ILEUS PARALYTIC 1 0.0002
606 HAEMOLYTIC ANAEMIA 2 0.0002
607 JAUNDICE 6 0.0002
608 MENINGITIS ASEPTIC 1 0.0002
609 IRON DEFICIENCY 1 0.0002
610 LEUKOCYTOSIS 4 0.0002
611 C-REACTIVE PROTEIN INCREASED 8 0.0002
612 PATHOGEN RESISTANCE 2 0.0002
613 ABDOMINAL HERNIA 1 0.0002
614 SKIN LESION 6 0.0002
615 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
616 ISCHAEMIA 1 0.0002
617 SHOCK 5 0.0002
618 MASS 3 0.0002
619 HYPONATRAEMIA 12 0.0002
620 SKIN REACTION 3 0.0002
621 BLINDNESS UNILATERAL 3 0.0002
622 DIALYSIS 3 0.0002
623 POST PROCEDURAL COMPLICATION 4 0.0002
624 GENERAL PHYSICAL HEALTH DETERIORATION 24 0.0002
625 ASPARTATE AMINOTRANSFERASE INCREASED 11 0.0002
626 ATELECTASIS 2 0.0002
627 GUILLAIN-BARRE SYNDROME 1 0.0002
628 PRESCRIBED OVERDOSE 4 0.0002
629 FLUID OVERLOAD 3 0.0002
630 RENAL TUBULAR NECROSIS 2 0.0002
631 DIABETIC NEUROPATHY 1 0.0002
632 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
633 NEOPLASM PROGRESSION 7 0.0002
634 HYPERNATRAEMIA 1 0.0002
635 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
636 CORONARY ARTERY STENOSIS 1 0.0002
637 HYPOTHERMIA 2 0.0002
638 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
639 PYREXIA 68 0.0002
640 HYPOPHAGIA 5 0.0002
641 FEMORAL NECK FRACTURE 1 0.0002
642 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
643 CACHEXIA 1 0.0002
644 INTENTIONAL PRODUCT USE ISSUE 17 0.0002
645 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
646 EJECTION FRACTION DECREASED 3 0.0002
647 MALABSORPTION 1 0.0002
648 CARDIO-RESPIRATORY ARREST 8 0.0002
649 INCONTINENCE 2 0.0002
650 SUDDEN DEATH 2 0.0002
651 DEEP VEIN THROMBOSIS 12 0.0002
652 OESOPHAGITIS 2 0.0002
653 ASPIRATION 2 0.0002
654 GASTRIC ULCER HAEMORRHAGE 1 0.0002
655 ALANINE AMINOTRANSFERASE INCREASED 11 0.0002
656 CELLULITIS 9 0.0002
657 SKIN INFECTION 2 0.0002
658 ACUTE PULMONARY OEDEMA 1 0.0002
659 BLOOD CALCIUM DECREASED 2 0.0002
660 BLOOD URIC ACID INCREASED 1 0.0002
661 PANCREATIC CARCINOMA 5 0.0002
662 METASTASES TO LUNG 2 0.0002
663 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
664 ORTHOSTATIC HYPOTENSION 3 0.0002
665 VASCULITIS 2 0.0002
666 OESOPHAGEAL CARCINOMA 5 0.0002
667 CHOLECYSTITIS 2 0.0002
668 MYOCLONUS 2 0.0002
669 CEREBRAL HAEMORRHAGE 6 0.0002
670 GANGRENE 1 0.0002
671 INGUINAL HERNIA 1 0.0002
672 CYTOPENIA 2 0.0002
673 ENCEPHALOPATHY 4 0.0002
674 CARDIAC FAILURE 13 0.0002
675 PHARYNGITIS 2 0.0002
676 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
677 HYPOCALCAEMIA 3 0.0002
678 LIVER DISORDER 7 0.0002
679 GASTRIC ULCER 3 0.0002
680 ACUTE RESPIRATORY FAILURE 3 0.0002
681 CARDIAC FLUTTER 1 0.0002
682 HIATUS HERNIA 2 0.0002
683 RESPIRATORY TRACT INFECTION 4 0.0002
684 DYSGRAPHIA 1 0.0002
685 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
686 CARDIAC FAILURE ACUTE 1 0.0001
687 COLITIS ISCHAEMIC 1 0.0001
688 BLINDNESS 6 0.0001
689 TACHYPNOEA 2 0.0001
690 COMA 7 0.0001
691 TACHYCARDIA 13 0.0001
692 BLOOD TESTOSTERONE DECREASED 1 0.0001
693 INFECTION 21 0.0001
694 JOINT EFFUSION 1 0.0001
695 LYMPHOEDEMA 1 0.0001
696 ENCEPHALITIS 1 0.0001
697 EXTRASYSTOLES 1 0.0001
698 DERMATITIS 3 0.0001
699 RASH MACULAR 5 0.0001
700 SINUS TACHYCARDIA 2 0.0001
701 METASTASIS 1 0.0001
702 DERMATITIS BULLOUS 1 0.0001
703 GASTROENTERITIS 2 0.0001
704 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
705 NEOPLASM MALIGNANT 9 0.0001
706 HYDRONEPHROSIS 1 0.0001
707 ATRIAL FIBRILLATION 13 0.0001
708 THERAPY NON-RESPONDER 6 0.0001
709 APHASIA 4 0.0001
710 PERICARDIAL EFFUSION 3 0.0001
711 EMOTIONAL DISORDER 4 0.0001
712 RASH PRURITIC 7 0.0001
713 HAEMORRHAGIC STROKE 1 0.0001
714 GASTROINTESTINAL INFLAMMATION 1 0.0001
715 GINGIVAL PAIN 1 0.0001
716 HYPOTENSION 25 0.0001
717 LIVER INJURY 3 0.0001
718 CHOLELITHIASIS 4 0.0001
719 METASTASES TO BONE 2 0.0001
720 OSTEONECROSIS 4 0.0001
721 VIRAL INFECTION 4 0.0001
722 PNEUMONIA ASPIRATION 3 0.0001
723 PERICARDITIS 2 0.0001
724 RENAL IMPAIRMENT 10 0.0001
725 INFUSION SITE ERYTHEMA 1 0.0001
726 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
727 SINUSITIS 12 0.0001
728 BLOOD MAGNESIUM DECREASED 1 0.0001
729 HAEMATOMA 3 0.0001
730 CARDIAC MURMUR 1 0.0001
731 OEDEMA PERIPHERAL 14 0.0001
732 CONTUSION 11 0.0001
733 NEUROTOXICITY 2 0.0001
734 IMMUNOSUPPRESSION 1 0.0001
735 DEHYDRATION 15 0.0001
736 CARDIAC FAILURE CONGESTIVE 9 0.0001
737 GALLBLADDER DISORDER 2 0.0001
738 FACIAL PAIN 1 0.0001
739 GASTROINTESTINAL INFECTION 1 0.0001
740 THROAT TIGHTNESS 3 0.0001
741 OEDEMA 6 0.0001
742 OSTEOMYELITIS 2 0.0001
743 HYPERGLYCAEMIA 4 0.0001
744 NERVE COMPRESSION 1 0.0001
745 BRONCHITIS 8 0.0001
746 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
747 HEPATIC STEATOSIS 2 0.0001
748 BREAST CANCER 10 0.0001
749 ERYTHEMA MULTIFORME 1 0.0001
750 BLOOD CREATININE INCREASED 7 0.0001
751 COGNITIVE DISORDER 5 0.0001
752 EPISTAXIS 8 0.0001
753 DYSARTHRIA 4 0.0001
754 OFF LABEL USE 93 0.0001
755 DYSPNOEA EXERTIONAL 4 0.0001
756 BLOOD SODIUM DECREASED 2 0.0001
757 COLITIS 4 0.0001
758 HAEMORRHAGE 11 0.0001
759 PULMONARY FIBROSIS 2 0.0001
760 CHILLS 12 0.0001
761 HEPATOMEGALY 1 0.0001
762 INJECTION SITE REACTION 7 0.0001
763 URINARY INCONTINENCE 3 0.0001
764 BLADDER DISORDER 1 0.0001
765 CYTOKINE RELEASE SYNDROME 2 0.0001
766 PROSTATE CANCER 8 0.0001
767 FLUID RETENTION 5 0.0001
768 MOTOR DYSFUNCTION 1 0.0001
769 BODY TEMPERATURE INCREASED 2 0.0001
770 INJECTION SITE WARMTH 2 0.0001
771 HYPERBILIRUBINAEMIA 1 0.0001
772 DYSPHAGIA 9 0.0001
773 OSTEOARTHRITIS 4 0.0001
774 BRADYCARDIA 5 0.0001
775 EATING DISORDER 2 0.0001
776 PRODUCT USE IN UNAPPROVED INDICATION 23 0.0001
777 DECREASED ACTIVITY 1 0.0001
778 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
779 DIARRHOEA 59 0.0001
780 GASTROINTESTINAL PAIN 1 0.0001
781 INJECTION SITE NODULE 1 0.0001
782 ABDOMINAL PAIN 21 0.0001
783 SKIN DISORDER 3 0.0001
784 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
785 PULMONARY OEDEMA 4 0.0001
786 NEPHROPATHY TOXIC 1 0.0001
787 EYE INFECTION 1 0.0001
788 MYOCARDIAL ISCHAEMIA 1 0.0001
789 ERYTHEMA 18 0.0001
790 MICTURITION URGENCY 1 0.0001
791 BONE PAIN 5 0.0001
792 BACTERAEMIA 1 0.0001
793 ACCIDENT 1 0.0001
794 HYPERLIPIDAEMIA 1 0.0001
795 RASH ERYTHEMATOUS 4 0.0001
796 BLOOD GLUCOSE DECREASED 4 0.0001
797 HEPATITIS C 1 0.0001
798 NEURALGIA 2 0.0001
799 DYSURIA 3 0.0001
800 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
801 DYSPEPSIA 8 0.0001
802 BRAIN OEDEMA 1 0.0001
803 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
804 HEPATITIS 2 0.0001
805 GASTROINTESTINAL DISORDER 7 0.0001
806 INFLAMMATION 4 0.0001
807 NODULE 1 0.0001
808 HYPERSENSITIVITY 14 0.0001
809 BLOOD PRESSURE DECREASED 5 0.0001
810 BREAST CANCER FEMALE 2 0.0001
811 MALIGNANT MELANOMA 1 0.0001
812 NEUROPATHY PERIPHERAL 7 0.0001
813 PNEUMONITIS 2 0.0001
814 ACUTE HEPATIC FAILURE 1 0.0001
815 RESPIRATORY ARREST 2 0.0001
816 HYPOMAGNESAEMIA 1 0.0001
817 WEIGHT DECREASED 20 0.0001
818 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
819 BRONCHOSPASM 1 0.0001
820 CARDIOGENIC SHOCK 1 0.0001
821 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
822 LIVER FUNCTION TEST ABNORMAL 2 0.0001
823 COVID-19 12 0.0001
824 CONFUSIONAL STATE 11 0.0001
825 LABORATORY TEST ABNORMAL 2 0.0001
826 HAEMORRHAGE INTRACRANIAL 1 0.0001
827 BLOOD POTASSIUM DECREASED 2 0.0001
828 BLOOD COUNT ABNORMAL 1 0.0001
829 MUSCULOSKELETAL CHEST PAIN 1 0.0001
830 CARDIAC DISORDER 6 0.0001
831 NERVOUS SYSTEM DISORDER 2 0.0001
832 MENINGIOMA 1 0.0001
833 CYANOSIS 1 0.0001
834 CYSTITIS 2 0.0001
835 ABSCESS 1 0.0001
836 BLOOD POTASSIUM INCREASED 1 0.0001
837 EYE DISORDER 2 0.0001
838 COAGULOPATHY 1 0.0001
839 SYNCOPE 6 0.0001
840 URINARY RETENTION 2 0.0001
841 CHEST PAIN 11 0.0001
842 FACE OEDEMA 1 0.0001
843 SKIN EXFOLIATION 5 0.0001
844 CONDITION AGGRAVATED 18 0.0001
845 HEMIPARESIS 1 0.0001
846 CIRCULATORY COLLAPSE 1 0.0001
847 HEPATIC ENZYME INCREASED 4 0.0001
848 URINARY TRACT INFECTION 10 0.0001
849 PARAESTHESIA 9 0.0001
850 FALL 19 0.0001
851 EOSINOPHILIA 1 0.0001
852 HYPERTENSION 12 0.0001
853 ISCHAEMIC STROKE 1 0.0001
854 ASTHENIA 21 0.0001
855 GOUT 1 0.0001
856 DRUG EFFECT DECREASED 3 0.0001
857 BONE DISORDER 1 0.0001
858 CONJUNCTIVITIS 1 0.0001
859 DYSGEUSIA 4 0.0001
860 INFLUENZA 6 0.0001
861 COUGH 15 0.0001
862 HEPATIC CIRRHOSIS 1 0.0001
863 UNEVALUABLE EVENT 4 0.0001
864 DEPRESSION 12 0.0001
865 FEELING JITTERY 1 0.0001
866 DIABETES MELLITUS 4 0.0001
867 GAIT DISTURBANCE 10 0.0001
868 ERUCTATION 1 0.0001
869 BACK PAIN 12 0.0001
870 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
871 PALPITATIONS 6 0.0001
872 BLADDER CANCER 3 0.0001
873 NAUSEA 40 0.0001
874 DISORIENTATION 2 0.0001
875 CATARACT 3 0.0001
876 FEEDING DISORDER 1 0.0000
877 FEELING HOT 3 0.0000
878 VOMITING 23 0.0000
879 TREATMENT FAILURE 4 0.0000
880 RHABDOMYOLYSIS 2 0.0000
881 POLLAKIURIA 2 0.0000
882 HALLUCINATION, VISUAL 1 0.0000
883 CEREBROVASCULAR ACCIDENT 8 0.0000
884 HYPOAESTHESIA 7 0.0000
885 LIVER FUNCTION TEST INCREASED 1 0.0000
886 RECTAL HAEMORRHAGE 2 0.0000
887 HYPOACUSIS 2 0.0000
888 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
889 MELAENA 1 0.0000
890 MUSCLE TWITCHING 1 0.0000
891 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
892 DECREASED APPETITE 10 0.0000
893 PRODUCT USE ISSUE 8 0.0000
894 PAIN 26 0.0000
895 TREMOR 7 0.0000
896 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
897 PULMONARY EMBOLISM 4 0.0000
898 RENAL CANCER 2 0.0000
899 PRODUCTIVE COUGH 2 0.0000
900 MENTAL IMPAIRMENT 1 0.0000
901 EXTRAPYRAMIDAL DISORDER 1 0.0000
902 AGEUSIA 1 0.0000
903 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
904 HAEMATEMESIS 1 0.0000
905 CHEST DISCOMFORT 4 0.0000
906 DRUG RESISTANCE 1 0.0000
907 DYSPNOEA 22 0.0000
908 ABDOMINAL DISTENSION 4 0.0000
909 MUSCULOSKELETAL PAIN 2 0.0000
910 SPEECH DISORDER 2 0.0000
911 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
912 CARDIAC ARREST 3 0.0000
913 ANAPHYLACTIC REACTION 2 0.0000
914 HAEMOPTYSIS 1 0.0000
915 OXYGEN SATURATION DECREASED 2 0.0000
916 EYE PAIN 2 0.0000
917 FLATULENCE 2 0.0000
918 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
919 ANGINA PECTORIS 1 0.0000
920 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
921 FATIGUE 27 0.0000
922 MYOCARDIAL INFARCTION 6 0.0000
923 DIZZINESS 17 0.0000
924 DEATH 29 0.0000
925 THERAPEUTIC RESPONSE DECREASED 2 0.0000
926 INJECTION SITE ERYTHEMA 4 0.0000
927 HEAD INJURY 1 0.0000
928 METABOLIC ACIDOSIS 1 0.0000
929 MOVEMENT DISORDER 1 0.0000
930 NIGHT SWEATS 1 0.0000
931 SWELLING FACE 2 0.0000
932 PRODUCT DOSE OMISSION 2 0.0000
933 IMPAIRED HEALING 1 0.0000
934 HEART RATE INCREASED 3 0.0000
935 INFUSION RELATED REACTION 2 0.0000
936 TOXICITY TO VARIOUS AGENTS 5 0.0000
937 HAEMATURIA 1 0.0000
938 ABDOMINAL PAIN UPPER 6 0.0000
939 GASTRIC DISORDER 1 0.0000
940 ARTHRALGIA 12 0.0000
941 HYPERKALAEMIA 1 0.0000
942 HEART RATE DECREASED 1 0.0000
943 DRUG EFFECT INCOMPLETE 1 0.0000
944 RASH 12 0.0000
945 UNDERDOSE 2 0.0000
946 INTESTINAL OBSTRUCTION 1 0.0000
947 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
948 THROMBOSIS 2 0.0000
949 INFLUENZA LIKE ILLNESS 2 0.0000
950 INJECTION SITE PAIN 7 0.0000
951 ANGIOEDEMA 1 0.0000
952 COLITIS ULCERATIVE 1 0.0000
953 ADVERSE DRUG REACTION 2 0.0000
954 VISION BLURRED 3 0.0000
955 OCULAR HYPERAEMIA 1 0.0000
956 PAIN IN EXTREMITY 6 0.0000
957 ACUTE KIDNEY INJURY 3 0.0000
958 CONSTIPATION 4 0.0000
959 MALAISE 8 0.0000
960 MEDICATION ERROR 1 0.0000
961 NECK PAIN 1 0.0000
962 ABDOMINAL DISCOMFORT 3 0.0000
963 BLISTER 1 0.0000
964 SEIZURE 2 0.0000
965 JOINT SWELLING 2 0.0000
966 NO ADVERSE EVENT 3 0.0000
967 DISCOMFORT 1 0.0000
968 LOSS OF CONSCIOUSNESS 2 0.0000
969 HYPERHIDROSIS 2 0.0000
970 INSOMNIA 4 0.0000
971 HEADACHE 9 0.0000
972 AGITATION 1 0.0000
973 BLOOD PRESSURE INCREASED 2 0.0000
974 HOSPITALISATION 2 0.0000
975 PRURITUS 5 0.0000
976 COMPLETED SUICIDE 1 0.0000
977 URTICARIA 2 0.0000
978 MYALGIA 2 0.0000
979 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
980 NASOPHARYNGITIS 2 0.0000
981 BLOOD GLUCOSE INCREASED 2 0.0000
982 DRUG INTOLERANCE 1 0.0000
983 FLUSHING 1 0.0000
984 WEIGHT INCREASED 2 0.0000
985 ASTHMA 1 0.0000
986 MUSCULAR WEAKNESS 1 0.0000
987 DRY SKIN 1 0.0000
988 ANXIETY 2 0.0000
989 DRUG INEFFECTIVE 8 0.0000
990 MUSCLE SPASMS 1 0.0000